Ironwood Pharmaceuticals Inc (IRWD): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$3.14M
Year ended 2020-12-31
-45.2%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2020-12-31 | $3.14M | -86.9% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $23.88M | -27.1% | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | $32.75M | +71.5% | 2021-02-17, From 2018-01-01 |
| 2017-12-31 | $19.10M | +922.3% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $1.87M | n/m | 2019-02-25, From 2016-01-01 |
| 2015-12-31 | $12.0K | -99.8% | 2018-02-22, From 2015-01-01 |
| 2014-12-31 | $5.29M | -26.5% | 2017-02-22, From 2014-01-01 |
| 2013-12-31 | $7.20M | +646.4% | 2016-02-19, From 2013-01-01 |
| 2012-12-31 | $965.0K | n/a | 2015-02-18, From 2012-01-01 |